Moore Capital Management’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
Other funds holding IMCR
KCM
Moore Capital Management's IMCR Position: Q3 2026 in Review
Moore Capital Management reduced its Immunocore (IMCR) stake by 30% in Q3 2026, selling an estimated $2.78M and leaving 193,045 shares worth $5.85M. The position accounts for 0.11% of the portfolio, ranked #165.
Moore Capital Management first reported a position in IMCR in Q1 2026 and has held it in 3 quarters since. The position peaked at $8.72M in Q2 2026. 130 funds tracked by Wall St. Rank hold IMCR as of Q3 2026.
- Moore Capital Management held 193,045 shares of Immunocore worth $5.85M as of Q3 2026.
- Moore Capital Management sold 81,618 Immunocore shares in Q3 2026, an estimated $2.78M.
- Immunocore made up 0.11% of Moore Capital Management's portfolio in Q3 2026, its #165 holding.
- Moore Capital Management first reported a position in Immunocore in Q1 2026 and has held it in 3 quarters since.
- Moore Capital Management's Immunocore position peaked at $8.72M in Q2 2026.
- 130 funds tracked by Wall St. Rank held Immunocore as of Q3 2026.
Based on Moore Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.